(ZhejiangPictorial) CHINA-ZHEJIANG-TAIZHOU-PRIVATE ECONOMY (CN)

(ZhejiangPictorial) CHINA-ZHEJIANG-TAIZHOU-PRIVATE ECONOMY (CN)

(240301) -- TAIZHOU, March 1, 2024 (Xinhua) -- Automated devices perform endurance tests on harmonic reducers for robots at Zhejiang FORE Intelligent Technology Co., Ltd. in Huangyan, Taizhou, east China's Zhejiang Province, Feb. 29, 2024. Private firms account for more than 99 percent of all enterprises in Taizhou, where the local authorities have continuously implemented diversified measures in recent years to promote high-quality development of the private economy. In 2023 alone, the city recorded an industrial added value of 222.994 billion yuan (about 30.98 billion U.S. dollars), with new energy, high-tech and strategic emerging industries becoming the new propellers of its industrial development. (Xinhua/Weng Xinyang)

GLOBALink | German auto company sees rapid growth in China's business-friendly environment

STORY: GLOBALink | German auto company sees rapid growth in China's business-friendly environment SHOOTING TIME: Nov. 29, 2023 DATELINE: Dec. 10, 2023 LENGTH: 0:02:18 LOCATION: SHANGHAI, China CATEGORY: ECONOMY SHOTLIST: 1. various of Lenze factory in Shanghai 2. STANDUP (English): ZHANG MENGJIE, Xinhua Correspondent 3. SOUNDBITE 1(English): SEAN XIE, President of Lenze East Asia & General manager of Lenze China 4. various of Lenze factory in Shanghai 5. SOUNDBITE 2 (English): SEAN XIE, President of Lenze East Asia & General manager of Lenze China STORYLINE: STANDUP (English): ZHANG MENGJIE, Xinhua Correspondent "Lenze is a German enterprise that focuses on intelligent manufacturing. It has a complete set of solutions at all levels, from controllers to drives to motor reducers. A lot of components are produced in these automatic production lines, and then transported to many globally recognized names in robot and new energy battery industry. Today, Lenze Shanghai has grown from a big production base to its

U.S. pharmacies limit sales of children's medications amid "tripledemic"

STORY: U.S. pharmacies limit sales of children's medications amid "tripledemic" DATELINE: Dec. 22, 2022 LENGTH: 00:01:18 LOCATION: NEW YORK, the United States CATEGORY: HEALTH SHOTLIST: 1. STANDUP (English): XIA LIN, Xinhua correspondent 2. various of a CVS store 3. various of the statement released by Walgreens 4. various of a CVS store 5. various of the Times Square, New York STORYLINE: STANDUP (English): XIA LIN, Xinhua correspondent "U.S. pharmacies CVS and Walgreens are limiting purchases of children's pain-relief medications amid a winter 'tripledemic' of respiratory viruses. CVS said in a statement it is restricting both in-person and online purchases of two children's pain relief products. Walgreens has also limited online purchases of six over-the-counter fever reducers per transaction. 'Due to increased demand and various supplier challenges, over-the-counter pediatric fever reducing products are seeing constraint across the country,' said Walgreens in a statement. A spokesperson for the U.S. Dep

Türkiye increases euro exchange rate for medicine prices by 36.77 pct

STORY: Türkiye increases euro exchange rate for medicine prices by 36.77 pct DATELINE: Dec. 15, 2022 LENGTH: 0:01:30 LOCATION: Ankara CATEGORY: ECONOMY SHOTLIST: 1. various of the medicines in a drugstore in Turkey (courtesy of ihlas news agency) 2. various of Turkish lira and euro STORYLINE: Türkiye on Wednesday raised the euro-lira exchange rate for medicine prices by 36.77 percent, the country's Official Gazette said on Wednesday, following a supply problem in pharmaceutical products. The euro fixed rate will be applied as 10.75 Turkish lira for medicine prices, according to the new calculation, which is still below the market rate of 19.85 lira per euro. As the gap between the pharmaceutical euro exchange rate and the real euro exchange rate widened, there were problems in the supply of medicines. Turkish citizens were hardly reaching many drugs such as antibiotics, painkillers and fever reducers in the past few months. Most of the drugs that cause supply problems are imported or productions that ar